Bromazepam

DB01558ApprovedIllicitSmall moleculeBenzodiazepines and benzodiazepine derivatives

Bromazepam is a short-acting benzodiazepine with intermediate onset commonly used to treat panic disorders and severe anxiety. It is a Schedule IV drug in the U.S. and Canada and under the Convention on Psychotropic Substances.

Chemical structure of Bromazepam
Mechanism
Curator reviewed
Primary indication
For the short-term treatment of insomnia, short-term treatment of anxiety or panic attacks, if a benzodiazepine is required, and the alleviation of the symptoms of alcohol- and opiate-withdrawal.Curator reviewed · 2 structured indications
Formula / weight
C14H10BrN3O · 316.153 g/mol (avg)
First approval
Canada, 1995
Code names
RO 5-3350

Resolves to

Compound
UNIIX015L14V0OCAS1812-30-2ChEMBLCHEMBL277062ChEBI31302PubChem2441KEGGD01245
Clinical / RWD
RxNorm1749ATCN05BA08PharmGKBPA10035
Structure
InChIKeyVMIYHDSEFNYJSL-UHFFFAOYSA-NSMILESBrC1=CC2=C(NC(=O)CN=C2C2=CC=CC=N2)C=C1
Targets
P47869GABRA2

What you can answer from here — as of September 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,509Drug interactionsStructured to mechanism, not free text
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
5ContraindicationsEach with its own population and attribute set
Sign in
168Marketed productsAcross 8 countries and 56 labellers
Sign in
1ATC codeIncluding every combination product, plus 25 drug categories
Sign in
19+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Bromazepam, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In